Gene-Chemical Interaction Annotations Click to see Annotation Detail View
Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | (-)-epigallocatechin 3-gallate | multiple interactions | EXP | | 6480464 | [potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of IMMP1L mRNA | CTD | PMID:22079256 | 1,2-dimethylhydrazine | decreases expression | ISO | Immp1l (Mus musculus) | 6480464 | 1 and 2-Dimethylhydrazine results in decreased expression of IMMP1L mRNA | CTD | PMID:22206623 | 1,2-dimethylhydrazine | multiple interactions | ISO | Immp1l (Mus musculus) | 6480464 | [1 and 2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of IMMP1L mRNA | CTD | PMID:22206623 | 14-Deoxy-11,12-didehydroandrographolide | decreases expression | EXP | | 6480464 | 14-deoxy-11 and 12-didehydroandrographolide results in decreased expression of IMMP1L mRNA | CTD | PMID:22101062 | 2,3,7,8-tetrachlorodibenzodioxine | affects expression | ISO | Immp1l (Mus musculus) | 6480464 | Tetrachlorodibenzodioxin affects the expression of IMMP1L mRNA | CTD | PMID:24680724 | 2,3,7,8-tetrachlorodibenzodioxine | increases expression | ISO | Immp1l (Mus musculus) | 6480464 | Tetrachlorodibenzodioxin results in increased expression of IMMP1L mRNA | CTD | PMID:25975270 | 4,4'-diaminodiphenylmethane | decreases expression | ISO | Immp1l (Mus musculus) | 6480464 | 4 and 4'-diaminodiphenylmethane results in decreased expression of IMMP1L mRNA | CTD | PMID:18648102 | aflatoxin B1 | decreases methylation | EXP | | 6480464 | Aflatoxin B1 results in decreased methylation of IMMP1L gene | CTD | PMID:27153756 | all-trans-retinoic acid | decreases expression | EXP | | 6480464 | Tretinoin results in decreased expression of IMMP1L mRNA | CTD | PMID:21934132 | antirheumatic drug | increases expression | EXP | | 6480464 | Antirheumatic Agents results in increased expression of IMMP1L mRNA | CTD | PMID:24449571 | Aroclor 1254 | increases expression | ISO | Immp1l (Mus musculus) | 6480464 | Chlorodiphenyl (54% Chlorine) results in increased expression of IMMP1L mRNA | CTD | PMID:23650126 | atrazine | decreases expression | EXP | | 6480464 | Atrazine results in decreased expression of IMMP1L mRNA | CTD | PMID:22378314 | bisphenol A | increases expression | ISO | Immp1l (Rattus norvegicus) | 6480464 | bisphenol A results in increased expression of IMMP1L mRNA | CTD | PMID:25181051 | bisphenol A | increases expression | ISO | Immp1l (Mus musculus) | 6480464 | bisphenol A results in increased expression of IMMP1L mRNA | CTD | PMID:32156529 and PMID:38074096 | carbon nanotube | decreases expression | ISO | Immp1l (Mus musculus) | 6480464 | Nanotubes and Carbon results in decreased expression of IMMP1L mRNA | CTD | PMID:25620056 | clothianidin | increases expression | EXP | | 6480464 | clothianidin results in increased expression of IMMP1L mRNA | CTD | PMID:31626844 | copper(II) sulfate | decreases expression | EXP | | 6480464 | Copper Sulfate results in decreased expression of IMMP1L mRNA | CTD | PMID:19549813 | coumestrol | multiple interactions | EXP | | 6480464 | [Coumestrol co-treated with resveratrol] results in increased expression of IMMP1L mRNA | CTD | PMID:19167446 | cyclosporin A | decreases expression | EXP | | 6480464 | Cyclosporine results in decreased expression of IMMP1L mRNA | CTD | PMID:20106945 and PMID:25562108 | dicrotophos | decreases expression | EXP | | 6480464 | dicrotophos results in decreased expression of IMMP1L mRNA | CTD | PMID:28302478 | dorsomorphin | multiple interactions | EXP | | 6480464 | [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of IMMP1L mRNA | CTD | PMID:27188386 | epoxiconazole | increases expression | ISO | Immp1l (Mus musculus) | 6480464 | epoxiconazole results in increased expression of IMMP1L mRNA | CTD | PMID:35436446 | folic acid | decreases expression | ISO | Immp1l (Mus musculus) | 6480464 | Folic Acid results in decreased expression of IMMP1L mRNA | CTD | PMID:25629700 | folic acid | multiple interactions | ISO | Immp1l (Mus musculus) | 6480464 | [1 and 2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of IMMP1L mRNA | CTD | PMID:22206623 | methylmercury chloride | decreases expression | EXP | | 6480464 | methylmercuric chloride results in decreased expression of IMMP1L mRNA | CTD | PMID:28001369 | paracetamol | decreases expression | EXP | | 6480464 | Acetaminophen results in decreased expression of IMMP1L mRNA | CTD | PMID:25704631 | paracetamol | increases expression | ISO | Immp1l (Rattus norvegicus) | 6480464 | Acetaminophen results in increased expression of IMMP1L mRNA | CTD | PMID:33387578 | perfluorooctane-1-sulfonic acid | decreases expression | EXP | | 6480464 | perfluorooctane sulfonic acid results in decreased expression of IMMP1L mRNA | CTD | PMID:27153767 | pirinixic acid | decreases expression | ISO | Immp1l (Mus musculus) | 6480464 | pirinixic acid results in decreased expression of IMMP1L mRNA | CTD | PMID:18445702 | pirinixic acid | increases expression | ISO | Immp1l (Mus musculus) | 6480464 | pirinixic acid results in increased expression of IMMP1L mRNA | CTD | PMID:23811191 | potassium chromate | decreases expression | EXP | | 6480464 | potassium chromate(VI) results in decreased expression of IMMP1L mRNA | CTD | PMID:22079256 | potassium chromate | multiple interactions | EXP | | 6480464 | [potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of IMMP1L mRNA | CTD | PMID:22079256 | quercetin | decreases expression | EXP | | 6480464 | Quercetin results in decreased expression of IMMP1L mRNA | CTD | PMID:21632981 | resveratrol | multiple interactions | EXP | | 6480464 | [Coumestrol co-treated with resveratrol] results in increased expression of IMMP1L mRNA | CTD | PMID:19167446 | SB 431542 | multiple interactions | EXP | | 6480464 | [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of IMMP1L mRNA | CTD | PMID:27188386 | sunitinib | decreases expression | EXP | | 6480464 | Sunitinib results in decreased expression of IMMP1L mRNA | CTD | PMID:31533062 | tetrachloromethane | decreases expression | ISO | Immp1l (Rattus norvegicus) | 6480464 | Carbon Tetrachloride results in decreased expression of IMMP1L mRNA | CTD | PMID:33387578 | thimerosal | increases expression | EXP | | 6480464 | Thimerosal results in increased expression of IMMP1L mRNA | CTD | PMID:27188386 | trichostatin A | decreases expression | EXP | | 6480464 | trichostatin A results in decreased expression of IMMP1L mRNA | CTD | PMID:24935251 and PMID:26272509 | trichostatin A | multiple interactions | EXP | | 6480464 | [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of IMMP1L mRNA | CTD | PMID:27188386 | tris(2-butoxyethyl) phosphate | affects expression | EXP | | 6480464 | tris(2-butoxyethyl) phosphate affects the expression of IMMP1L mRNA | CTD | PMID:29024780 | valproic acid | decreases methylation | EXP | | 6480464 | Valproic Acid results in decreased methylation of IMMP1L gene | CTD | PMID:29154799 | valproic acid | increases expression | EXP | | 6480464 | Valproic Acid results in increased expression of IMMP1L mRNA | CTD | PMID:28001369 and PMID:29154799 | valproic acid | affects expression | EXP | | 6480464 | Valproic Acid affects the expression of IMMP1L mRNA | CTD | PMID:25979313 | valproic acid | decreases expression | EXP | | 6480464 | Valproic Acid results in decreased expression of IMMP1L mRNA | CTD | PMID:24935251 | vorinostat | increases expression | EXP | | 6480464 | vorinostat results in increased expression of IMMP1L mRNA | CTD | PMID:27188386 | |